Profile
The Female Health Company (FHC) is the maker of the FC Female Condom (FC1 and FC2), a revolutionary option offering women dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy.
FHC was created as a worldwide company in February 1996 with the purchase of Chartex Resources Ltd., the holder of exclusive worldwide rights to FC1.
The corporation holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People?s Republic of China, South Korea and Japan. Patents are pending for FC2.
FHC is the sole manufacturer and marketer of the FC1 and FC2 Female Condoms in the world. FHC and its partners currently market the Female Condom under FC Female CondomŽ, FC2 Female CondomŽ, RealityŽ, FemidomŽ, FemyŽ, and CareŽ in the rest of the world.
Product
The Female Condom is designed for use by women to help prevent HIV/AIDS, other sexually transmitted diseases and unintended pregnancy. Currently the Female Condom is available in two materials: FC1 is made of polyurethane and is manufactured in London. FC2 is made of a nitrile polymer and manufactured in Malaysia and in India. FC1 and FC2 look the same; each has a soft, thin sheath which lines the vagina and covers the labia during intercourse; the condom is held in place with a soft ring at each end.
Clinical studies in the United States and Japan show that FC1 is 95 percent to 98 percent efficacious in protecting against pregnancy when used correctly and consistently. Studies have shown FC1 to be a highly effective barrier to the viruses and bacteria that cause sexually transmitted diseases, including HIV/AIDS. Studies have shown that FC2 is functionally equivalent to FC1.
FC1 is currently sold or available through various channels in 116 countries. It is commercially marketed directly to consumers in 15 countries by various country-specific partners, including in the United States, the United Kingdom, Canada and France. Currently, public sector female condom programs in various stages are ongoing in over 90 countries. FC2 is available in 77 countries outside the United States.
|
|
|